Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Dec 22, 2017 5:14pm
94 Views
Post# 27219477

RE:RE:RE:RE:RE:Twas the night before xmas!!!

RE:RE:RE:RE:RE:Twas the night before xmas!!!
macman1519 wrote: Bunge, that is too undervalued! When Roger announces a bidding war, 2.40 will be passed in the second  week of the three month process,  by the end of the three month JV seeking process, between 10 and 15 dollars is where we will be.. Please don't sell us off so cheaply!! The miracle of a bidding war, with our amazing science that holds so much future promise in so many cancer treatments for so many,  can be started next week!! All we need is for someone to wake Roger up!!! The most frustrating stock management I've been associated with!!! An amazingly obvious solution to ALL THE ISSUES FACING HIS COMPANY, AND HE MAKES NO EFFORT TO PURSUE IT, SO FAR!!! ROGER, START THE BIDDING WAR, RELY ON UR SCIENCE, ALL PROBLEMS SOLVED!!!! ITS A YAZ, A NO BRAINER!!! AND YET, ROGER SITS, THINKING? THE RODAN STATUE OF THE THINKER COMES TO MIND!!! COME ON ROG, JUST TRY A BIDDING WR, ONLY 5% OF THE COMPANY WILL GET U SO MUCH MORE!!! TRY IT, YOU'LL LIKE IT!!!!!!! . HOW CAN IT GET ANY WORSE??? 

uote=Bunge]All future TLT CEO Macman wants for Xmas is someone paying $2.40 for something currently worth 24 pennies.

That WOULD be a Christmas (Festivus for you unbelievers) MIRACLE.


[/quote]

In fact just only a jv seeking NR is needed, during the long process of JV seeking from big pharmaceutical companies as a JV partner,a lots of warranty would executed and the company would have more than enough money to run multiple indications of cancer human trial,and not necessarily take any low ball offers , and in this way RW is in driver's position in the whole game in stead of being abused as Stockholm syndrome partner. And the company has no obligation to take any offers even if it's the highest of all. It's that easy,just a JV seeking NR will change everything.
Bullboard Posts